Trauma and the immune response

Journal of the Royal Society of Medicine

Volumn 91, Issue 8, 1998, Pages 417-420

  Smith, R M ^a   Giannoudis, P V ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; REACTIVE OXYGEN METABOLITE;

ADULT RESPIRATORY DISTRESS SYNDROME; CARDIOVASCULAR SYSTEM; CELLULAR IMMUNITY; DEATH; ENDOTHELIUM; HEAD INJURY; HUMAN; HYPOVOLEMIA; HYPOXIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; INJURY; LEUKOCYTE; MULTIPLE ORGAN FAILURE; SHORT SURVEY; TRAUMATOLOGY;

EID: 0031709519     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107689809100805     Document Type: Short Survey

References (52)

1. Burdett-Smith P, Airey M, Franks A. Improvements in trauma survival in Leeds. Injury 1995;26(7):455-8
2. Cipolle MD, Pasquale MD, Cerra FB. Secondary organ dysfunction: from clinical perspectives to molecular mediators. Crit Care Clinics 1993;9:261-97
3. Moore FA, Moore EE. Evolving concepts in the pathogenesis of post injury multiple organ failure. Surg Clin N Am 1995;75:257-77
4. Moore FA, Moore EE, Read RA. Postinjury multiple organ failure: Role of extrathoracic injury and sepsis in adult respiratory distress syndrome. N Horizons 1993;1(4):538-49
5. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leuco Biol 1994;55:662-75
6. Youn YK, LaLonde C, Demling R. The role of mediators in the response to thermal injury. World J Surg 1992;16:30-6
7. Bradley JR, Wilks D, Rubenstein D. The vascular endothelium in septic shock. J Infection 1994;28:1-10
8. Roten R, Markert M, Feihl F, et al. Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am Rev Resp Dis 1991;143:590-2
9. Chollet Martin S, Jourdain B, Gilbert C, et al. Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS. Am J Resp Crit Care Med 1996;154:594-601
10. Abraham E, Jesmok G, Tuder R, et al. Contribution of TNF-α to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med 1995;23(8):1319-26
11. Rabinovici R, John R, Esser K, et al. Serum tumour necrosis factor-alpha profde in trauma patients. J Trauma 1993;35:698-701
12. Fox BA, Lamb WR, Roberts TE et al. Early cytokine response to multiple injury. Injury 1993;24(6):373-6
13. Hoch RC, Rodriguez R, Manning T, et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993;21:834-45
14. Bairgie RJ, Lamont PM, Kwiatkowski D, et al. Systemic cytokine response after major surgery. Br J Surg 1992;79:757-60
15. Ayala A, Wang P, Ba ZF, et al. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 1991;29:R167-R171
16. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-a in disease states and inflammation. Crit Care MEd 1993;21:S447-S463
17. Tan LR, Waxman K, Scannell G, et al. Trauma causes early release of soluble receptors for tumor necrosis factor. J Trauma 1993;34:634-8
18. Ertel W, Keel M, Bonaccio M, et al. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 1995;59:879-87
19. Roumen RMH, Hendriks T, Van der Ven-Jongekrijg, et al. Cytokine patterns in patients after major vascular surgery, haemorrhagic shock and severe blunt trauma: Relationship with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993;218:769
20. Rodriguez JL, Miller CG, Garner WL, et al. Correlation of the local and systemic cytokine response with clinical outcome following thermal injury. J Trauma 1993;34:684
21. Botha AJ, Moore FA, Moore EE, et al. Sequential systemic platelet-activating factor and IL-8 primes neutrophils in patients with trauma at risk of multiple organ failure. Br J Surg 1996;83:1407-12
22. Cruickshank AM, Fraser WD, Burns HJ, et al. Response of serum interleukin-6 in patient undergoing elective surgery of varying severity. Clin Sci 1990;79:161-5
23. Hoch RS, Rodriquez RM, Manning T, et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993;21:839-45
24. Giannoudis PV, Smith RM, Ramsden CW, et al. Molecular mediators and trauma; effects of accidental trauma on the production of plasma elastase, IL-6 sICAM-1 and sE-selectin. Injury 1996;27:372
25. Renaldo JE, Rogers RE. Adult respiratory distress syndrome: changing concepts of lung injury and repair. N Engl J Med 1982; 306:900-16
26. Wortel C, Doerschuck C. Neutrophils and neutrophil-endothelial cell adhesion in adult respiratory distress syndrome. N Horizons 1993;4:632-7
27. Windsor AC, Mullen PG, Fowler AA, et al. Role of the neutrophil in adult respiratory distress syndrome. Br J Surg 1993;80:10-7
28. Fujishica S, Aikawa N. Neutrophil mediated tissue injury and its modulation. Intern Care Med 1995;21:277-85
29. Springer SA. Adhesion receptors of the immune system. Nature 1990;346:425-34
30. Smith CW. Leukocyte endothelial cell interactions. Semin Haematol 1995;30:45-55
31. Varani J, Bendelow MS, Scaley DE, et al. Tumor necrosis factor enhances susceptibility to vascular endothelium to neutrophil mediated killing. J Lab Invest 1988;59:292-5
32. Smith CW, Marlin SD, Rothlein R, et al. Co-operative interaction of LFA-1 and MAC-1 with ICAM in facilitating adherence and transendothelial migration. J Clin Invest 1989;83:2008-17
33. Gordon MG, Robertson CE, Dawes J. Neutrophil elastase levels and major trauma in man. Intens Care Med 1992;15:543-8
34. Simms HH, D'Amiro R. Increased PMN CD11b/CD18 expression following post-traumatic ARDS. J Surg Res 1991;50:362-7
35. Redl H, Nikolai A, Kneidinger R, et al. Endothelial and leukocyte activation in experimental polytrauma and sepsis. Behring Inst Mitt 1993;92:218-28
36. Cioffi WG, Burleson PG, Pruitt BA JR. Leukocytes responses to injury. Arch Surg 1993;128:1260-7
37. Giannoudis PV, Smith RM, Banks RE, et al. Stimulation of inflammatory markers after blunt trauma. Shock 1997;7:44
38. Polk HC Jr. Non-specific host defence stimulation in the reduction of surgical infections in man. J Surg 1987;74:969-70
39. Polk HC Jr. The enhancement of host defences against infection-search of the Holygrail? Surgery 1986;99:1-6
40. Meakins JL, Pietsch JB, Bubenick O, et al. Delayed hypersensitivity indicator of acquired failure of host defences in spesis and trauma. Ann Surg 1997;186:241-50
41. Utoh J, Yamamoto J, Utsunowiya T, et al. Effect of surgery on neutrophil functions, superoxide and leukotrine production. Br J Surg 1988;75:682-5
42. Creswell P. Antigen recognition by T lymphocytes. Immunol Today 1987;8:67
43. Wakefield CH, Carey PD, Foulds S, et al. Changes in major histocompatibility class II expression in monocytes and T-cells of patients developing sepsis afler surgery. Br J Surg 1993;80:205-9
44. Hershman MJ, Cheadle WG, Wellhousen SR, et al. Monocyte HLA-DR antigen expression characterization clinical outcome in the trauma patient. Br J Surg 1990;77:204-7
45. Cheadle WG, Hershman MJ, Wellhousen SR, et al. HLA-DR expression on peripheral blood monocyes correlates with surgical infection. Am J Surg 1991;181:639-45
46. Klava A, Windsor ACJ, Farmely SM, et al. IL-10: A role in the development of postoperative immunosuppresion. Arch Surg 1997;132(4):425-9
47. Guillou PJ. Biological variation in the development of sepsis after surgery. Lancet 1993;342:217-20
48. Stuber F, Petersen M, Bokelmann F, et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-a concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-4
49. Salmon JE, Edberg JC, Brogle NL. Allelic polymorphisms of human Fcγ receptor lia and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 1992;89: 1274-81
50. Giannoudis PV, Smith RM, Guillou PJ, et al. HLA-DR expression and intrapulmonary shunt following trauma. Shock 1997;7:57
51. Reinhart K, Wiegand-Lohnert C, Grimminger F, et al. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody fragment, MAK 195F in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled dose ranging study. Crit Care Med 1996;24:733-42
52. Fisher CJ, Chainault JF, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results of a randomized double-blind placebo controlled trial. Phase II rhIL I Sepsis Study Group. JAMA 1994;27:1836-43